Green Thumb Renews $50 Million Buyback After Cutting Share Count 5.6%

Green Thumb Industries is extending its share repurchase program for another year, giving the multistate cannabis operator authority to buy back up to $50 million of its subordinate voting shares as management weighs acquisitions, organic investment and its own discounted stock.

The new normal course issuer bid will begin September 23, 2026, and expire September 22, 2027. Green Thumb said purchases may be made through the Canadian Securities Exchange, the OTCQX Best Market, or alternative trading systems. Acquired shares will be returned to treasury and canceled.

The authorization does not obligate Green Thumb to spend the full amount. The timing, volume, and price of any purchases will depend on market conditions, securities regulations, and whether management sees better returns elsewhere. The company also said it does not expect to borrow to finance the program.

That flexibility matters, but Green Thumb’s repurchase record gives the announcement more weight than an authorization alone. Since its first program began in September 2023, the company has repurchased the equivalent of approximately 29.5 million shares for $203.4 million.

“Since launching our first repurchase program in 2023, we have returned more than $200 million to shareholders through share buybacks, including more than $80 million in 2026,” founder, Chairman, and CEO Ben Kovler said in a press release on Monday. “As we continue to evaluate the best uses of our capital—from investing in organic growth to pursuing M&A opportunities—renewing this program gives us the flexibility to continue buying back stock when conditions present an attractive opportunity.”

The Share Count Is Actually Falling

The distinction between announcing a buyback and executing one is particularly important in cannabis. Operators may authorize large programs but use only a small portion of them, while stock compensation, acquisitions and option exercises continue adding shares.

Green Thumb’s recent SEC filings show that its purchases are producing a real net reduction.

During the first six months of 2026, Green Thumb repurchased 13.44 million subordinate voting shares for approximately $77.7 million, paying an average of $5.78 per share. Over the same period, the company issued approximately 1.93 million shares through restricted stock unit vesting, nearly 14,000 through option exercises, and roughly 13,000 to nonemployee contractors.

After accounting for those issuances, subordinate voting shares outstanding declined from 206.63 million at the end of 2025 to 195.15 million on June 30, 2026. That represents a net reduction of approximately 11.48 million shares, or 5.6%, in six months.

But gross repurchase figures can overstate the benefit to continuing shareholders. If a company buys back the same number of shares it issues as compensation, the program prevents dilution but does not increase each remaining shareholder’s percentage ownership. Green Thumb bought back substantially more shares than it issued during the period.

Assuming the underlying business remains stable, a smaller denominator can increase earnings, cash flow, and book value per share. It also leaves every remaining share with a larger proportional claim on the company. Purchasing stock below management’s estimate of intrinsic value can transfer value toward shareholders who remain invested.

Buying Back High-Vote Shares

Green Thumb also used part of its 2026 repurchase spending to reduce its super voting share class.

In May, the company entered into private transactions to acquire 2,500 super voting shares from Kovler and another 2,500 from President and director Anthony Georgiadis. The price was based on the $7.80 closing price of the underlying subordinate voting shares on the transaction date.

Each super voting share is exchangeable for 100 subordinate voting shares but carries 1,000 votes. The transactions therefore represented 500,000 subordinate-share equivalents and removed 5 million votes from the super voting class.

Green Thumb’s outstanding super voting shares fell from 201,690 at the beginning of 2026 to 196,690 at June 30, a reduction of approximately 2.5%. The transaction does not eliminate the company’s multiclass structure or concentrated insider voting power. It does, however, modestly simplify the equity profile while retiring a portion of the company’s highest-vote securities.

That governance dimension could become more relevant if federal reform eventually allows plant-touching cannabis operators to pursue listings on major U.S. exchanges and attract a broader institutional shareholder base. Thus, a lower share count could make the capital structure easier for investors to evaluate.

The Cash Behind the Program

Green Thumb’s ability to execute distinguishes its program from buyback announcements made by companies with limited liquidity.

The operator ended June with $283.6 million in cash and cash equivalents and $405.5 million in working capital. It had $218.8 million of current liabilities, and cash remained above its year-end 2025 level, even after the first-half repurchases.

In 2025, Green Thumb generated $294.9 million in operating cash flow, up from $195.2 million in 2024. After approximately $81.1 million in capital expenditures, the company produced roughly $213.9 million of operating cash flow less capital spending. That is not identical to the company’s own definition of free cash flow, but it shows the cash-generation capacity supporting acquisitions, investments, and shareholder returns.

The board initially authorized $50 million under the program that began in September 2025, then expanded the authorization to $150 million in April 2026. As of June 30, approximately $62.3 million remained available under that program. Green Thumb said it ultimately returned more than $80 million through buybacks during 2026 before renewing the authorization at $50 million for the next 12 months.

The new amount is smaller than the expanded $150 million ceiling, reinforcing that the program is intended as a flexible capital-allocation tool rather than a promise to spend at any price.

Buybacks Versus Dilution

Green Thumb has not eliminated future dilution. At June 30, the company had approximately 9.71 million unvested restricted stock units and 7.19 million options outstanding. It recorded $21.1 million in stock-based compensation during the first half and expected another $62.5 million of unrecognized compensation expense to be recorded over a weighted-average period of 1.86 years.

The company also says stock-based compensation is expected to remain an important tool for attracting and retaining employees. Investors should therefore continue tracking net share-count movement rather than repurchases in isolation.

So far, however, the direction is clear. Green Thumb repurchased 13.44 million subordinate shares in the first half while issuing fewer than 2 million. The program is shrinking the outstanding base.

That makes Green Thumb’s strategy unusual within a capital-constrained industry.

What Investors Should Watch

The next test is execution under the renewed authorization. Because Green Thumb is not required to buy any shares, the $50 million headline should not automatically be added to the amount already returned.

Investors should watch the average purchase price, the number of subordinate and high-vote shares canceled, new equity issuance, and the effect of buybacks on liquidity. They should also compare repurchases with capital expenditures, M&A, and debt obligations to determine whether buying stock remains the company’s highest-return use of incremental cash.